INFUSIONSVORRICHTUNG

Patent europeic · EP4108270 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4108270
Numer da la dumonda
EP22181441
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
22-05-2014
Publitgà
28-12-2022
Concedì
13-08-2025
La protecziun finescha il pli tard
21-05-2034
Proxima taxa annuala scadenta
31-05-2027
Classas IPC
A61M 5/142 (2006.01)
A61M 39/24 (2006.01)
A61M 5/145 (2006.01)
A61M 5/168 (2006.01)
A61M 5/172 (2006.01)
A61M 5/36 (2006.01)
A61M 5/38 (2006.01)
Prioritad
US 201361826863 P 23.05.2013
Derivà da
EP17188587
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 24-06-2026

    Midada

    Published in Swissreg on 24.06.2026

  2. 01-06-2026

    Next annual fee due on

    Next annual fee due on
    31.05.2026 → 31.05.2027

    Published in Swissreg on 01.06.2026

  3. 17-11-2025

    Represchentant inscrit

    Representative
    Stolmár & Partner Intellectual Property S.à.r.l., Bahnhofstrasse 11, 6210 Sursee

    Published in Swissreg on 17.11.2025

  4. 13-08-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 13.08.2025

Partidas

Possessur

NewIV Medical Corp.

196 West Ashland Street, Doylestown PA 18901, US

Represchentant

Stolmár & Partner Intellectual Property S.à.r.l.

Bahnhofstrasse 11, 6210 Sursee

Inventur

CARLISLE, Jeffrey, A.

Stratham, NH 03885, US

KUBA, Lawrence, M.

Nashua, NH 03062, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.